Identification of new possible targets for leukemia treatment by kinase activity profiling
- 6 December 2010
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 52 (1) , 122-130
Abstract
To date, the biology of acute leukemia has been unclear, and defining new therapeutic targets without prior knowledge remains complicated. The use of high-throughput techniques would enable us to learn more about the biology of the disease, and make it possible to directly assess a broader range of therapeutic targets. In this study we have identified comprehensive tyrosine kinase activity profiles in leukemia samples using the PamChip® kinase activity profiling system. Strikingly, 31% (44/120) of the detected peptides were active in all three groups of leukemia samples. The recently reported activity of platelet-derived growth factor receptor (PDGFR) and neurotrophic tyrosine kinase receptors (NTRK1 and NTRK2) in leukemia could be appreciated in our array results. In addition, high levels of peptide phosphorylation were demonstrated for peptides related to macrophage stimulating 1 receptor (MST1R). A provisional signal transduction scheme of the common active peptides was constructed and used to specifically select an inhibitor for leukemic blast cell survival assays. As expected, a dose-dependent decrease in leukemic blast cell survival was achieved for all leukemia samples. Our data demonstrate that kinase activity profiling in leukemic samples is feasible and provides novel insights into the pathogenesis of leukemia. This approach can be used for the rapid discovery of potential drug targets.Keywords
This publication has 23 references indexed in Scilit:
- Targeting Multiple Kinase Pathways: A Change In ParadigmClinical Cancer Research, 2010
- Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target DiscoveryCancer Research, 2009
- High-affinity neurotrophin receptors and ligands promote leukemogenesisBlood, 2009
- Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23)Leukemia, 2008
- RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemiaBlood, 2008
- Evidence for a Minimal Eukaryotic Phosphoproteome?PLOS ONE, 2007
- Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoterOncogene, 2007
- Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemiaBlood, 2006
- Activated EGFR Promotes the Survival of B-Lineage Acute Leukemia in the Absence of Stromal CellsCell Cycle, 2005
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002